As part of the Best of MASCC 2020 virtual conference, 29 innovative research proposals were submitted by early-career investigators and clinicians working in supportive cancer care. After thorough evaluation, 6 proposals were awarded research grants, recognizing excellence in supportive care research.
Final Recipients
Dr. Atul Batra
All India Institute of Medical Sciences, Delhi
Project: A Randomized Phase II Open-Label Study of Topical Diclofenac Versus Physician Directed Measures In Prevention of Capecitabine Associated Hand-Foot Syndrome.
Award: 1st Prize
Researcher at All India Institute of Medical Sciences, Delhi, specializing in dermatologic complications of cancer therapy and prevention strategies.
Dr. Vinod Sharma
All India Institute of Medical Sciences, Delhi
Project: A Phase III Randomized, double-blinded, placebo-controlled, superiority trial to assess the role of NK-1 receptor antagonist as anti-emetic agent for highly emetogenic chemotherapy.
Award: 2nd Prize (Joint)
Clinical researcher at AIIMS Delhi focusing on antiemetic therapy optimization and chemotherapy-induced nausea and vomiting management.
Ms. Chaitali Gavandalkar
Tata Memorial Centre, Mumbai
Project: A study to evaluate the effectiveness of foot bathing in prevention of oxaliplatin induced peripheral neuropathy amongst patients with Colorectal cancer who receiving chemotherapy in a day care center at a tertiary cancer hospital.
Award: 2nd Prize (Joint)
Nursing researcher at Tata Memorial Centre specializing in non-pharmacological interventions for chemotherapy-induced peripheral neuropathy.
Dr. Sujay Srinivas
Tata Memorial Centre, Mumbai
Project: A randomized, double blinded, parallel-group, phase 3 study to investigate the efficacy and tolerability of palonosetron, dexamethasone, aprepitant plus oral cannabinoid versus palonosetron, dexamethasone and aprepitant alone in patients receiving highly emetogenic chemotherapeutic (HEC) regimens.
Award: 3rd Prize (Joint)
Medical oncologist at Tata Memorial Centre researching innovative antiemetic combinations including cannabinoid-based therapies.
Dr. Simran Kaur
All India Institute of Medical Sciences, Delhi
Project: Neural correlates of chemotherapy induced cognitive deficits in non-metastatic osteosarcoma and role of cognitive rehabilitation: A QEEG study.
Award: 3rd Prize (Joint)
Researcher at AIIMS Delhi studying chemotherapy-induced cognitive impairment and developing neurological rehabilitation strategies for cancer patients.
Dr. Seema Gulia
Tata Memorial Centre, Mumbai
Project: Avoiding prophylactic growth factors during Paclitaxel phase of dose dense adjuvant chemotherapy in breast cancer.
Award: 3rd Prize (Joint)
Breast cancer specialist at Tata Memorial Centre focused on optimizing supportive care protocols and growth factor usage in adjuvant chemotherapy.
Impact Summary
The grants supported cutting-edge research in areas including hand-foot syndrome prevention, antiemetic therapy, peripheral neuropathy prevention, cognitive rehabilitation, and growth factor optimization. These projects have contributed to advancing evidence-based supportive care practices.
Grant Information
Status
Total Award Amount
Rs. 21,00,000 distributed across six research grants.
Recipients
6
Published Date
October 4, 2020
Authors
IASCC
MASCC